Home/Bone-Rad/John S. Wimer

JS

John S. Wimer

CEO, COO, Chairman of the Board

Therapeutic Areas

Oncology Musculoskeletal

Bone-Rad Pipeline

Drug	Indication	Phase
Spine-Rad™ Cement	Tumors in bone (primary and metastatic), initially targeting the spine	Pre-clinical

Leadership Team at Bone-Rad

Dr. Harry B. Skinner

Dr. Sean M. Tutton

Medical Advisory Board Member

View full Bone-Rad profile